These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1976066)

  • 21. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
    Saghir SA; Clark AJ; McClymont EL; Staley JL
    Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose and species dependent pharmacokinetics of a novel sigma receptor antagonist, DuP 734.
    Kapil RP; Lam GN
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):3-20. PubMed ID: 7620836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig.
    Goyarts T; Dänicke S
    Toxicol Lett; 2006 Jun; 163(3):171-82. PubMed ID: 16326049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.
    Li J; Milne RW; Nation RL; Turnidge JD; Smeaton TC; Coulthard K
    J Antimicrob Chemother; 2004 May; 53(5):837-40. PubMed ID: 15044428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zidovudine bioavailability and linear pharmacokinetics in female B6C3F1 mice.
    Trang JM; Prejean JD; James RH; Irwin RD; Goehl TJ; Page JG
    Drug Metab Dispos; 1993; 21(1):189-93. PubMed ID: 8095218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single dose pharmacokinetics and bioavailability of butyryl glucosamine in the rat.
    Aghazadeh-Habashi A; Ibrahim A; Carran J; Anastassiades T; Jamali F
    J Pharm Pharm Sci; 2006; 9(3):359-64. PubMed ID: 17207418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicokinetics of inhaled 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in F344 rats and B6C3F1 mice.
    Dill JA; Lee KM; Bates DJ; Anderson DJ; Johnson RE; Chou BJ; Burka LT; Roycroft JH
    Toxicol Appl Pharmacol; 1998 Dec; 153(2):227-42. PubMed ID: 9878593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
    Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
    Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent kinetics of cilastatin in laboratory animals.
    Lin JH; Chen IW; Ulm EH
    Drug Metab Dispos; 1989; 17(4):426-32. PubMed ID: 2571484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
    Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
    J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration.
    Woodworth JR; Owens SM; Mayersohn M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicokinetics of lambda-cyhalothrin in rats.
    Anadón A; Martínez M; Martínez MA; Díaz MJ; Martínez-Larrañaga MR
    Toxicol Lett; 2006 Aug; 165(1):47-56. PubMed ID: 16513299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicokinetics of N-nitrosodimethylamine in the Syrian golden hamster.
    Streeter AJ; Nims RW; Wu PP; Logsdon DL
    Arch Toxicol; 1990; 64(7):562-6. PubMed ID: 2073129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicokinetics of 2-methylimidazole in male and female F344 rats.
    Johnson JD; Reichelderfer D; Zutshi A; Graves S; Walters D; Smith C
    J Toxicol Environ Health A; 2002 Jun; 65(12):869-79. PubMed ID: 12079612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N-benzyl derivative of the glucosidase inhibitor 1-deoxynojirimycin shows a prolonged half-life and a more complete oral absorption in the rat compared with the N-methyl analog.
    Faber ED; van den Broek LA; Oosterhuis EE; Stok BP; Meijer DK
    Drug Deliv; 1998; 5(1):3-12. PubMed ID: 19570011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bioavailability and nonlinear clearance of (-)-carbovir in the rat.
    Huang SH; Remmel RP; Zimmerman CL
    Pharm Res; 1991 Jun; 8(6):739-43. PubMed ID: 2062804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose toxicokinetics of aluminum in the rat.
    Wilhelm M; Zhang XJ; Hafner D; Ohnesorge FK
    Arch Toxicol; 1992; 66(10):700-5. PubMed ID: 1290402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of N-nitrodimethylamine and N-nitromethylamine in the rat.
    Hassel M; Frei E; Streeter AJ; Wiessler M
    Carcinogenesis; 1990 Mar; 11(3):357-60. PubMed ID: 2311177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.